Items tagged with HIV coinfection
Global Phase 3 “STAND” trial launched to test new tuberculosis drug regimen PaMZ to shorten, improve treatment (post with simple image)
STAND trial will take place in approximately 50 study sites in Africa, Asia, Caribbean, Eastern Europe, and Latin America; Results published in The Lancet show PaMZ’s promise to dramatically shorten and simplify therapy for patients with drug-resistant TB; Regimen could improve treatment for those with drug-sensitive TB and those with HIV co-infection.
The Lancet: Results of Phase 2b trial of novel TB regimen PaMZ show potential to shorten, improve TB treatment (post with simple image)
Phase 3 STAND trial launched to advance PaMZ through final stage of testing.
Global HIV & TB: Heightened Impact - CDC annual meeting concludes in Atlanta (post with simple image)
5 June 2015 – Today concludes a full week of packed sessions that the new CDC Division of Global HIV & TB had as part of their Annual Meeting under the overall umbrella Global HIV & TB: Heightened Impact.
UNAIDS announces that the goal of 15 million people on life-saving HIV treatment by 2015 has been met nine months ahead of schedule (post with simple image)
Tuberculosis remains a leading cause of death among people living with HIV, accounting for one in five AIDS-related deaths globally. However, between 2004 and 2014, TB deaths declined by 33% thanks to the rapid increase in antiretroviral treatment, which reduces the risk that a person living with HIV will develop TB by 65%.
HIV i-Base/TAG: 2015 Pipeline Report (post with simple image)
Latest annual review on HIV, HCV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure, and immune-based and gene therapies in development.
MSF report: HIV/TB counselling: who is doing the job? (post with simple image)
New MSF report surveying lay counsellor policies across eight countries highlights major weaknesses for adherence support.
Successes in HIV overshadow failures in TB (post with simple image)
In the new world of intensifying budget competition -- flat global health budgets, a widening post-2015 agenda, growing demand to address other non-communicable diseases -- TB is very vulnerable to becoming even more lost.
WHO policy guidance: The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active TB in people living with HIV (post with simple image)
The World Health Organization (WHO) has evaluated a new diagnostic test - Alere DetermineTM - a urine lateral flow lipoarabinomannan assay (LF-LAM,) to determine its suitability for use in the screening or diagnosis of tuberculosis disease.
Webinar: Current guidelines and treatment developments for HIV/TB co-infection (post with simple image)
Join the European AIDS Treatment Group for a Webinar on Monday, Dec. 14, 4 to 5 PM. CET to discuss the current HIV/TB co-infection epidemic and treatment guidelines as well as the health products pipeline currently under development.
Tuberculosis: opportunities and challenges for the 90–90–90 targets in HIV-infected children (post with simple image)
TB may be an important barrier to achievement of the 90–90–90 targets, but specific attention to TB care in HIV-infected children may provide important opportunities to enhance the care of both TB and HIV in children.
Page 32 of 36 · Total posts: 0←First 31 32 33 Last→